10x Genomics Reports Strong Q1 Profitability Improvement and Launches New Atera Platform

summarizeSummary

10x Genomics reported significantly reduced Q1 operating and net losses, alongside the launch of its new Atera platform and a substantial increase in cash reserves, while maintaining full-year revenue guidance.

check_boxKey Events

• Q1 2026 Financial Results

  Revenue for the first quarter of 2026 was $150.8 million, a 3% decrease year-over-year. Excluding $16.8 million in one-time license and royalty revenue from Q1 2025, revenue increased by 9%.

• Significant Loss Reduction

  Operating loss improved significantly to $17.0 million from $39.3 million in the prior year period. Net loss also substantially decreased to $13.5 million from $34.4 million year-over-year.

• New Product Launch: Atera

  The company launched Atera, a new platform for spatial whole-transcriptome analysis, which is expected to begin shipping in the second half of 2026. Management highlighted it as the most significant product introduction in company history.

• Maintained Full-Year Guidance

  10x Genomics maintained its full-year 2026 revenue guidance of $600 million to $625 million, representing 0% to 4% growth over full-year 2025, excluding non-recurring license and royalty revenue.

auto_awesomeAnalysis

10x Genomics delivered a strong first quarter, significantly reducing its operating and net losses, which aligns with the trend of improved financial performance noted in the previous 10-K. The launch of Atera, described as the most significant product introduction in the company's history, signals a major step in its strategic growth initiatives. While reported revenue saw a slight decrease, the underlying 9% growth in core business, excluding one-time items, indicates a healthy operational trajectory. The substantial increase in cash reserves further strengthens the company's financial position, providing ample resources for continued innovation and market expansion. Investors should monitor the adoption and revenue contribution of the Atera platform in the second half of 2026.